Elenco degli articoli con argomento «pemfigo»

Dermatologia

05 feb 2024

Sustained Remission Without Corticosteroids Among Patients With Pemphigus

The Ritux 3 trial demonstrated the short-term efficacy and safety of first-line treatment with rituximab

08 gen 2024

Sexual quality of life in patients with pemphigus

Pemphigus, an autoimmune blistering disease that affects the skin and mucous membranes, significantly impairs the quality of life (QoL)

31 mar 2023

S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune

Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi-organ involvement

05 set 2022

Updated S2K guidelines on the management of pemphigus vulgaris

Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized

18 lug 2022

Updated S2K guidelines on the management of pemphigus

Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin.

19 ott 2021

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials.

28 giu 2021

The burden of neurological comorbidities

Apart from bullous pemphigoid (BP), the association of other autoimmune bullous diseases (AIBDs) with neurological conditions is poorly understood.

10 mar 2021

Updated international expert recommendations

The SARS-CoV-2 pandemic has worsened since publication

21 set 2020

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology

Pemphigus encompasses a group of life‐threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin.

09 giu 2020

Long-term Outcomes of Rituximab Therapy in Pemphigus

J Eur Acad Dermatol Venereol. 2020 May 4. doi: 10.1111/jdv.16561. Epub ahead of print. PMID: 32367562.

25 feb 2020

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Several European countries recently developed international diagnostic and management guidelines for pemphigus, which have been instrumental in the standardization of pemphigus management.

09 dic 2019

Prurito: che cosa lo può provocare, come si controlla e quando è spia di problemi seri navigation-next-alternate

Se si escludono le punture di insetti, nella maggior parte dei casi la ragione di quell’impulso è da ricercare in una patologia dermatologica. Ma anche in alcune abitudini scorrette e malattie sistemiche

08 ott 2018

Diagnosis of bullous pemphigoid and pemphigus and surrounding subclinical lesions

Diagnosis of bullous pemphigoid (BP) and pemphigus is based on clinical features, histology, immunofluorescence and laboratory data.

25 giu 2018

Italian guidelines in pemphigus. Adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology And Venerology (EADV)

Pemphigus is a life threatening autoimmune epidermal blistering disease involving skin and mucous membranes. Pemphigus usually affects middle age men and women involving oral mucosa first and then spreading on the skin

01 set 2014

Guideline on the Diagnosis and Treatment of Autoimmune bullous diseases: Pemphigus

Developed by the Guideline Subcommittee of the European Dermatology Forum